Ryan H. Moy, Md, Phd

This study is testing whether a combination of two oral drugs, avutometinib and defactinib, can help people live longer and slow the growth of a specific, hard-to-treat type of stomach cancer that has spread. It is for adults whose cancer has continued to grow despite prior chemo…